Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
Dan Labriola, ND, Director, Naturopathic Services, Swedish Cancer Institute, Seattle, WA, discusses complementary therapy with the treatment of cancer. References and Resources Eliott JA, Kealey CP, Olver IN.…
The CDC’s FluView, a weekly influenza surveillance report prepared by the influenza division, posts the statistics for influenza week 6, February 3 – February 9, 2008. References and…
Josh Levitsky, MD, Assistant Professor, Division of Hepatology from Northwestern University provides an overview of the treatment of hepatitis C. References and Resources Seef, LB, Hoofnagle, JH. National…
Josh Levitsky, MD, Assistant Professor, Division of Hepatology from Northwestern University provides an overview of the epidemiology and diagnosis of hepatitis C. References and Resources Armstrong GL. The…
